🇺🇸 FDA
Pipeline program

Drug 601

SSGJ-601-DME-I-01

Phase 1 small_molecule active

Quick answer

Drug 601 for Diabetic Macular Edema is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Diabetic Macular Edema
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials